Lemaitre Vascular (LMAT) EPS (Weighted Average and Diluted) (2010 - 2026)
Lemaitre Vascular (LMAT) reported EPS (Weighted Average and Diluted) of $0.68 for Q1 2026, up 41.67% year-over-year from $0.48 in Q1 2025, and little changed on a QoQ basis from $0.68 in Q4 2025.
Lemaitre Vascular (LMAT) has 17 years of EPS (Weighted Average and Diluted) data on file, last reported at $0.68 in Q1 2026.
- Quarterly EPS (Weighted Average and Diluted) rose 41.67% year-over-year to $0.68 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.71 (up 37.56% YoY) and the FY2025 annual result came in at $2.52, up 30.57% from the prior year.
- EPS (Weighted Average and Diluted) was little changed at $0.68 in Q1 2026 per LMAT's latest filing, from $0.68 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $0.75 in Q3 2025 and bottomed at $0.16 in Q2 2022.
- The 5-year median for EPS (Weighted Average and Diluted) is $0.44 (2024), against an average of $0.43.
- The widest annual swing landed in 2022, when EPS (Weighted Average and Diluted) sank 60.0%; it then soared 125.0% in 2023.
- Tracing LMAT's EPS (Weighted Average and Diluted) over 5 years: stood at $0.25 in 2022, then surged by 52.0% to $0.38 in 2023, then gained by 26.32% to $0.48 in 2024, then soared by 41.67% to $0.68 in 2025, then advanced by 0.0% to $0.68 in 2026.
- Per Business Quant, the three latest LMAT EPS (Weighted Average and Diluted) figures stand at $0.68 (Q1 2026), $0.68 (Q4 2025), and $0.75 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 2.28 |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -1.11 |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 2.74 |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 1.92 |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 0.07 |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 0.66 |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 1.57 |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -0.03 |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 1.12 |
| 10 | Lemaitre Vascular | 2.28 Bn | 1.91 Bn | 48.40 Mn | 0.68 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.68 |
| Dec 31, 2025 | 0.68 |
| Sep 30, 2025 | 0.75 |
| Jun 30, 2025 | 0.60 |
| Mar 31, 2025 | 0.48 |
| Dec 31, 2024 | 0.48 |
| Sep 30, 2024 | 0.49 |
| Jun 30, 2024 | 0.52 |
| Mar 31, 2024 | 0.44 |
| Dec 31, 2023 | 0.38 |
| Sep 30, 2023 | 0.33 |
| Jun 30, 2023 | 0.36 |
| Mar 31, 2023 | 0.27 |
| Dec 31, 2022 | 0.25 |
| Sep 30, 2022 | 0.25 |
| Jun 30, 2022 | 0.16 |
| Mar 31, 2022 | 0.27 |
| Dec 31, 2021 | 0.28 |
| Sep 30, 2021 | 0.30 |
| Jun 30, 2021 | 0.40 |
| Mar 31, 2021 | 0.28 |
| Dec 31, 2020 | 0.34 |
| Sep 30, 2020 | 0.37 |
| Jun 30, 2020 | 0.17 |
| Mar 31, 2020 | 0.16 |
| Dec 31, 2019 | 0.23 |
| Sep 30, 2019 | 0.25 |
| Jun 30, 2019 | 0.23 |
| Mar 31, 2019 | 0.17 |
| Dec 31, 2018 | 0.30 |
| Sep 30, 2018 | 0.21 |
| Jun 30, 2018 | 0.43 |
| Mar 31, 2018 | 0.19 |
| Dec 31, 2017 | 0.21 |
| Sep 30, 2017 | 0.25 |
| Jun 30, 2017 | 0.23 |
| Mar 31, 2017 | 0.16 |
| Dec 31, 2016 | 0.13 |
| Sep 30, 2016 | 0.17 |
| Jun 30, 2016 | 0.14 |
| Mar 31, 2016 | 0.11 |
| Dec 31, 2015 | 0.13 |
| Sep 30, 2015 | 0.11 |
| Jun 30, 2015 | 0.10 |
| Mar 31, 2015 | 0.08 |
| Dec 31, 2014 | 0.11 |
| Sep 30, 2014 | 0.05 |
| Jun 30, 2014 | 0.08 |
| Mar 31, 2014 | -0.01 |
| Dec 31, 2013 | 0.05 |
| Sep 30, 2013 | 0.05 |
| Jun 30, 2013 | 0.06 |
| Mar 31, 2013 | 0.05 |
| Dec 31, 2012 | 0.04 |
| Sep 30, 2012 | 0.04 |
| Jun 30, 2012 | 0.05 |
| Mar 31, 2012 | 0.02 |
| Dec 31, 2011 | 0.02 |
| Sep 30, 2011 | 0.08 |
| Jun 30, 2011 | 0.03 |
| Mar 31, 2011 | 0.00 |
| Dec 31, 2010 | 0.12 |
| Sep 30, 2010 | 0.09 |
| Jun 30, 2010 | 0.09 |